|
MechanismRARα antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date25 Sep 2000 |
100 Clinical Results associated with Orsenix, LLC
0 Patents (Medical) associated with Orsenix, LLC
100 Deals associated with Orsenix, LLC
100 Translational Medicine associated with Orsenix, LLC